Alkoholizm i Narkomania - Alcoholism and Drug Addiction is a prominent peer-reviewed journal published by the Institute of Psychiatry and Neurology, Department of Studies on Alcoholism in Warsaw, Poland. Renowned for its commitment to advancing the fields of addiction research and mental health, this journal disseminates critical findings regarding the prevention, treatment, and societal implications of alcoholism and drug addiction. Since becoming Open Access in 2017, it ensures that researchers, professionals, and students from across the globe have unrestricted access to valuable resources and emerging studies within this vital area of public health. The journal emphasizes innovative methodologies and interdisciplinary approaches, inviting contributions that explore the complex interplay of psychological, social, and biological factors influencing addiction. By fostering a collaborative and inclusive scholarly community, Alkoholizm i Narkomania aims to contribute significantly to the understanding and resolution of addiction-related challenges worldwide.

The Journal of Addictions Nursing, published by Lippincott Williams & Wilkins, serves as a pivotal resource in the field of psychiatric and mental health nursing. With an ISSN of 1088-4602 and an E-ISSN of 1548-7148, this esteemed journal has been dedicated to advancing the knowledge and practice of addiction nursing since its inception in 1989. As of 2023, it ranks in the Q3 category of psychiatry and mental health, highlighting its significance amidst its peers. The journal provides a platform for the dissemination of original research, reviews, and clinical practices that address the complexities of addiction treatment and care. While it currently does not offer open access options, its valuable insights are accessible to practitioners and researchers committed to improving patient outcomes. With content spanning from 1989 to 2024, the journal continues to shape the discourse in this vital area of nursing, making it an essential read for professionals and scholars aiming to stay at the forefront of addiction nursing and intervention strategies.

Substance Abuse is a premier scholarly journal published by SAGE Publications Inc, dedicated to advancing the understanding and treatment of substance use disorders. With an established presence from 1995 to 2023, the journal boasts an impressive Q1 ranking in both Medicine (miscellaneous) and Psychiatry and Mental Health, positioning it among the top tier of academic publications in these fields. Researchers and professionals will find its articles, which are grounded in rigorous empirical studies and innovative interventions, essential for addressing the complex and multifaceted nature of substance abuse. Although not an open access publication, Substance Abuse maintains a commitment to sharing valuable insights and findings, making it a vital resource for those looking to enhance their knowledge and practice. Located in Thousand Oaks, CA, this journal serves as a critical forum for international dialogue and research dissemination, ensuring that current trends and challenges in substance use are thoughtfully examined and discussed within the academic community.

BIPOLAR DISORDERS, published by Wiley, is a leading international journal dedicated to advancing the understanding and treatment of bipolar disorders. Since its establishment in 1999, the journal has become a vital resource in the fields of Biological Psychiatry and Psychiatry and Mental Health, currently ranked in the Q2 category for Biological Psychiatry and Q1 for Psychiatry and Mental Health as of 2023. With impressive Scopus rankings, it stands at 75th out of 567 in Psychiatry and Mental Health and 11th out of 51 in Biological Psychiatry, reflecting its influential role in shaping mental health research. The journal not only focuses on empirical studies, reviews, and clinical reports but also encourages innovative methodological advancements in understanding bipolar disorders. Although it does not offer Open Access, its extensive coverage from 1999 to 2024 ensures that practitioners, researchers, and students have access to a wealth of knowledge critical for the development of effective therapeutic interventions. For those engaging with cutting-edge research in psychiatric care, BIPOLAR DISORDERS serves as an essential platform for knowledge dissemination and academic discourse.

Welcome to the Journal of Addiction Medicine, a premier academic resource devoted to the field of addiction studies, published by LIPPINCOTT WILLIAMS & WILKINS. Since its inception in 2007, this esteemed journal has become a leader in disseminating groundbreaking research, with impressive rankings in the Q1 quartile across key disciplines such as Medicine (Miscellaneous), Pharmacology (Medical), and Psychiatry and Mental Health, reflecting its significance in the scholarly community. With an ISSN of 1932-0620 and an E-ISSN of 1935-3227, it caters to a diverse audience of researchers, clinicians, and students seeking to expand their understanding of addiction medicine. The journal's articles are primarily published in a non-open access format, ensuring high-quality research is accessible through institutional subscriptions. With a Scopus ranking that positions it within the top tiers of several relevant categories, the Journal of Addiction Medicine is essential for anyone committed to advancing knowledge in the field and addressing the complexities surrounding addiction.

DRUG AND ALCOHOL REVIEW, published by Wiley, is a leading journal dedicated to advancing the scholarship in the fields of drug and alcohol research. Since its inception in 1989, this esteemed publication has provided a critical platform for the dissemination of innovative research findings, reviews, and theoretical papers, addressing pressing issues in substance use and addiction. With an impact factor that places it in the Q1 category in both Health (social science) and Medicine (miscellaneous), it ranks #78 out of 371 in the Scopus index for Health and #115 out of 398 in Medicine, reflecting its significant influence and high citation rates among scholars. The journal is committed to fostering a multidisciplinary approach, integrating perspectives from psychology, sociology, public health, and medicine, to inform policy and practice. Accessible to researchers and practitioners alike, *DRUG AND ALCOHOL REVIEW* serves as an essential resource for anyone invested in understanding and addressing the complexities of drug and alcohol use in society.

Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.

Sucht-Zeitschrift für Wissenschaft und Praxis, published by HOGREFE AG in Switzerland, is a pivotal journal addressing the interrelated fields of addiction science and mental health. With an ISSN of 0939-5911 and an E-ISSN of 1664-2856, this journal has been dedicated to fostering interdisciplinary research and practical applications since its inception in 1991, continuing through to 2024. As a respected source in the field, it holds a 2023 Q3 quartile ranking in Medicine (miscellaneous), a Q4 ranking in Psychiatry and Mental Health, and a Q3 ranking in Public Health, highlighting its broad relevance and growing impact on contemporary health discussions. While currently not offering open access options, the journal provides a rich platform for researchers, practitioners, and students to share and gain insights into innovative practices and scientific findings that advance the understanding of addiction and its societal implications. With its contributions indexed in Scopus and a variety of rankings reflective of its quality, Sucht-Zeitschrift für Wissenschaft und Praxis serves as an essential resource for those committed to advancing knowledge and practice in addiction-related fields.

The Journal of Studies on Alcohol and Drugs is a premier academic journal dedicated to advancing the understanding of alcohol and drug use, its effects, and its societal implications. Published by ALCOHOL RES DOCUMENTATION INC at the Center for Alcohol Studies, Rutgers University, this journal features comprehensive research that spans the disciplines of health, psychiatry, mental health, and toxicology. With its Q1 ranking in Health (Social Science) and Q2 ranking in Psychiatry and Mental Health, the journal plays a vital role in disseminating high-impact research that informs policy, prevention, and treatment strategies in addiction and substance use. The journal contributes significantly to the field, as evidenced by its solid Scopus rankings and engagement with contemporary issues, making it an essential resource for researchers, practitioners, and students. Although it does not offer open access, the journal's commitment to rigorous peer review and scholarship ensures that it remains at the forefront of research on alcohol and drugs through its converged publication timeline from 2007 to 2024.

JOURNAL OF DRUG ISSUES, published by SAGE PUBLICATIONS INC, serves as a pivotal platform for researchers and professionals dedicated to the multifaceted exploration of drug-related topics across various fields, including health, medicine, psychiatry, and public health. With an ISSN of 0022-0426 and an E-ISSN of 1945-1369, this esteemed journal has maintained a consistent output since its inception in 1971 and is set to continue its contributions through 2024. Reflecting its high academic standards, it has achieved a Q2 ranking in Health (Social Science) and Q3 rankings in several related categories, underscoring its relevance and influence among scholarly work. The journal is indexed in Scopus, with respectable rankings in various medical and health-related disciplines, highlighting its role as an essential resource for those invested in the vigorous discourse surrounding drug issues. Although not an open-access publication, the journal ensures that access to its extensive research findings remains available to a broad audience, solidifying its importance in advancing knowledge and informing best practices in the field.